Clayton Partners’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,000
| Closed | -$207K | – | 36 |
|
|
2023
Q3 | $207K | Buy |
+7,000
| New | +$207K | 0.18% | 36 |
|
|
2023
Q2 | – | Sell |
-92,772
| Closed | -$199K | – | 37 |
|
|
2023
Q1 | $199K | Hold |
92,772
| – | – | 0.19% | 30 |
|
|
2022
Q4 | $184K | Sell |
92,772
-7,228
| -7% | -$14.3K | 0.17% | 30 |
|
|
2022
Q3 | $167K | Buy |
+100,000
| New | +$167K | 0.19% | 30 |
|
|
2021
Q2 | – | Sell |
-6,667
| Closed | -$126K | – | 39 |
|
|
2021
Q1 | $126K | Buy |
+6,667
| New | +$126K | 0.12% | 33 |
|